Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS1501 in Acute-on-chronic Liver Failure (ACLF)
NCT06916585Phase 2Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of AS1501 in acute-on-chronic liver failure (ACLF), sponsored by Shenzhen Third People's Hospital. Started Jun 2026; status: recruiting.
02
Drugs
AS1501
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT06916585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06916585.